Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 1
1993 1
1995 1
1996 4
1997 2
1998 3
2000 1
2001 2
2002 2
2003 1
2004 1
2005 2
2006 2
2007 1
2008 1
2010 2
2011 2
2012 4
2013 1
2014 1
2015 2
2020 1
2021 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan.
Yin O, Iwata H, Lin CC, Tamura K, Watanabe J, Wada R, Kastrissios H, AbuTarif M, Garimella T, Lee C, Zhang L, Shahidi J, LaCreta F. Yin O, et al. Among authors: kastrissios h. Clin Pharmacol Ther. 2021 Oct;110(4):986-996. doi: 10.1002/cpt.2291. Epub 2021 Jun 10. Clin Pharmacol Ther. 2021. PMID: 33999422 Free PMC article.
Population pharmacokinetics of daptomycin.
Dvorchik B, Arbeit RD, Chung J, Liu S, Knebel W, Kastrissios H. Dvorchik B, et al. Among authors: kastrissios h. Antimicrob Agents Chemother. 2004 Aug;48(8):2799-807. doi: 10.1128/AAC.48.8.2799-2807.2004. Antimicrob Agents Chemother. 2004. PMID: 15273084 Free PMC article. Clinical Trial.
Reporting guidelines for population pharmacokinetic analyses.
Dykstra K, Mehrotra N, Tornøe CW, Kastrissios H, Patel B, Al-Huniti N, Jadhav P, Wang Y, Byon W. Dykstra K, et al. Among authors: kastrissios h. J Clin Pharmacol. 2015 Aug;55(8):875-87. doi: 10.1002/jcph.532. J Clin Pharmacol. 2015. PMID: 26148467
Reporting guidelines for population pharmacokinetic analyses.
Dykstra K, Mehrotra N, Tornøe CW, Kastrissios H, Patel B, Al-Huniti N, Jadhav P, Wang Y, Byon W. Dykstra K, et al. Among authors: kastrissios h. J Pharmacokinet Pharmacodyn. 2015 Jun;42(3):301-14. doi: 10.1007/s10928-015-9417-1. Epub 2015 Apr 30. J Pharmacokinet Pharmacodyn. 2015. PMID: 25925797 Free PMC article.
Medication compliance as a feature in drug development.
Kastrissios H, Blaschke TF. Kastrissios H, et al. Annu Rev Pharmacol Toxicol. 1997;37:451-75. doi: 10.1146/annurev.pharmtox.37.1.451. Annu Rev Pharmacol Toxicol. 1997. PMID: 9131261 Review.
Population pharmacokinetics of esaxerenone, a novel non-steroidal mineralocorticoid receptor blocker, in patients with essential hypertension, patients with diabetic nephropathy, and healthy volunteers.
Yoshihara K, Fukae M, Kastrissios H, Wada R, Shimizu T, Ishizuka H. Yoshihara K, et al. Among authors: kastrissios h. Drug Metab Pharmacokinet. 2023 Oct;52:100516. doi: 10.1016/j.dmpk.2023.100516. Epub 2023 Jun 7. Drug Metab Pharmacokinet. 2023. PMID: 37690271 Free article.
Exposure-response analysis of the efficacy and safety of esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with or without diabetic kidney disease.
Yoshihara K, Fukae M, Kastrissios H, Wada R, Shimizu T. Yoshihara K, et al. Among authors: kastrissios h. Drug Metab Pharmacokinet. 2024 Apr;55:100535. doi: 10.1016/j.dmpk.2023.100535. Epub 2023 Oct 19. Drug Metab Pharmacokinet. 2024. PMID: 38245949 Free article.
42 results